Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension

Cited in blog · Diabetes, Obesity and Metabolism. · 2022

Wilding, J. P. H., et al. (2022). *Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension*. Diabetes, Obesity and Metabolism.